Katrin Dubischar-Kastner

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

Katrin Dubischar-Kastner, Susanne Eder, Vera Buerger et al. · Vaccine · 2010 · 65 citations

Vaccination, Vaccine Safety, Vaccine Development +6

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

A. Kaltenböck, Katrin Dubischar-Kastner, Elisabeth Schuller et al. · Vaccine · 2009 · 63 citations

Primary Immunodeficiency, Allergy, Autoimmune Disease +9

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

A. Kaltenböck, Katrin Dubischar-Kastner, Gerald Eder et al. · Vaccine · 2009 · 57 citations

Vaccinology, Vaccine Safety, Vaccination +12

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

Susanne Eder, Katrin Dubischar-Kastner, Christa Firbas et al. · Vaccine · 2011 · 56 citations

Vaccination, Vaccine Development, Immunology +5

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®

Elisabeth Schuller, Anton Klingler, Katrin Dubischar-Kastner et al. · Vaccine · 2011 · 46 citations

Vaccination, Vaccine Safety, Vaccine Ixiaro® +8